Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label multicenter Phase 3 study of IgPro10 in chronic immune thrombocytopenic purpura
2004-000537-11Phase 3Completed
- Sponsor
- CSL Behring
- Start
- Sep 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of immune serum globulin in immune thrombocytopenia (ITP), sponsored by CSL Behring. Primary endpoint: Platelet response within 7 days. Started Sep 2004; status: completed.
02
Drugs
immune serum globulin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on 2004-000537-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000537-11.